LAIR1 and breast carcinoma: In solid tumors, the overexpression of LAIR1 has been shown on the surfaces of cancer cells in epithelial ovarian cancer [56], cervical cancer [57], breast cancer [58], oral squamous cell carcinoma (OSCC) [59], hepatocellular carcinoma [60], and renal cell carcinoma (RCC) [61], whereas the expression of this IR was not detected in normal equivalent tissue.